News Daily News Un Estudio Revela un Sorprendente Rango de Riesgo Post-IAM entre Pacientes con Diabetes L.A. McKeown May 26, 2016
News Daily News Study Shows Surprising Range of Risk After Acute MI Among Patients With Diabetes L.A. McKeown May 26, 2016
News Daily News A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG Yael L. Maxwell May 13, 2016
News Daily News Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG Yael L. Maxwell May 13, 2016
News Daily News Everolimus Stent Better Than Paclitaxel Stent in Diabetic Patients, Even Those Requiring Insulin: TUXEDO Analysis Michael O'Riordan April 25, 2016
News Daily News Análisis del TUXEDO: Los Stents de Everolimus son Mejores que los de Paclitaxel en Pacientes Diabéticos, Incluso en Insulinodependientes Michael O'Riordan April 25, 2016
News Daily News Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs Michael O'Riordan March 25, 2016
News Daily News Cada Vez Más Evidencias Confirman que No hay un Mayor Riesgo de Insuficiencia Cardíaca asociado a los Fármacos Antidiabéticos basados en la Incretina Michael O'Riordan March 25, 2016
News Conference News ESC 2015 Ezetimibe Benefits Diabetics, and Does Not Increase Risk of New-Onset Diabetes Yael L. Maxwell September 01, 2015
News Conference News ESC 2015 FREEDOM Substudy: CABG, PCI Outcomes Affected by Baseline BP Yael L. Maxwell August 30, 2015
News Daily News El Subestudio SORT OUT III Apunta a Diferencias en la Eficacia de los Stents Liberadores de Fármacos (SLF) según el Estado Diabético Todd Neale November 17, 2014
News Daily News SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status Todd Neale November 17, 2014